彝医防治斯色病(类风湿关节炎)专家共识

标题: 彝医防治斯色病(类风湿关节炎)专家共识
title: Expert consensus on prevention and treatment of SiSe disease (rheumatoid arthritis) by Yi medicine
版本: 原创版
version: Original
分类: 专家共识
classification: Experts consensus
领域: 综合
field: Comprehensive guideline
国家和地区: 中国
Country and region: China
指南使用者: 本规范适用于指导民族医医院、中医院、中西医结合医院、综合医院、基层医院等的彝医、中医、中西医结合医务人员,在临床实践中参考本共识,为类风湿关节炎患者提供更加全面和个体化的治疗方案。
Guide users: This specification is applicable to guide the medical personnel of Yi medicine, traditional Chinese medicine, traditional Chinese medicine and integrated Chinese and Western medicine in ethnic medicine hospitals, Chinese medicine hospitals, integrated Chinese and Western medicine hospitals, general hospitals and grassroots hospitals, etc., to refer to this Consensus in their clinical practice and to provide patients with rheumatoid arthritis with a more comprehensive and individualized treatment plan.
证据分级方法: 证据检索与专家共识结合
Evidence grading method: Evidence search combined with expert consensus
制定单位: 云南省中医医院(云南中医药大学第一附属医院)、楚雄彝族自治州中医医院、四川省凉山彝族自治州中西医结合医院
Formulating unit: Yunnan province hospital of traditional Chinese medicine (yunnan university first affiliated hospital of traditional Chinese medicine), Chuxiong Yi autonomous prefecture of traditional Chinese medicine hospital, Liangshan Hospital of integrated Traditional and Westem Medicine
注册时间: 2024-10-07
Registration time:
注册编号: PREPARE-2024CN728
Registration number:
指南制订的目的: 彝医防治斯色病(类风湿关节炎)具有独特的优势和临床疗效,但目前尚未建立规范的彝医药斯色病(类风湿关节炎)专家共识。本专家共识着眼于发挥彝医药特色优势,规范彝医药防治类风湿关节炎临床实践,指导医师临床决策,提升彝医药的影响力和认可度。
Purpose of the guideline: Yi medicine offers distinctive advantages and clinical efficacy in the prevention and treatment of sarcoidosis (rheumatoid arthritis). However, there is currently no standardized expert consensus on Yi medicine for sarcoidosis (rheumatoid arthritis). This expert consensus aims to fully leverage the distinctive advantages of Yi medicine, standardize the clinical practice of Yi medicine in the prevention and treatment of rheumatoid arthritis, guide physicians in clinical decision-making, and enhance the influence and recognition of Yi medicine.